Biomaterial Database

Determination of thymol in halothane anaesthetic preparations by high-performance liquid chromatography. 1989

R D Thompson, and M Carlson

US Food and Drug Administration, Pharmaceutical Analysis Section, Minneapolis, MN 55401.

A high-performance liquid chromatographic (HPLC) procedure has been developed for the isolation and quantification of thymol, a stabilizing agent present in halothane anaesthetic preparations. The method offers improvements in specificity and simplicity with respect to a current official procedure for thymol in halothane. Results for commercial preparations obtained by the proposed procedure demonstrate excellent precision and accuracy with RSD values for replicate analysis ranging from 0.11 to 0.74% and recoveries via fortification from 99.6 to 100.1%. The HPLC method was compared to compendial procedures for thymol bulk substance and halothane products. Chromatographic separation of other related phenolic preservatives used in pharmaceuticals suggests a more extensive application of the proposed procedure.

UI	MeSH Term	Description	Entries
D010636	Phenols	Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D002851	Chromatography, High Pressure Liquid	Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed.	Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005079	Excipients	Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc.	Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D006221	Halothane	A nonflammable, halogenated, hydrocarbon anesthetic that provides relatively rapid induction with little or no excitement. Analgesia may not be adequate. NITROUS OXIDE is often given concomitantly. Because halothane may not produce sufficient muscle relaxation, supplemental neuromuscular blocking agents may be required. (From AMA Drug Evaluations Annual, 1994, p178)	1,1,1-Trifluoro-2-Chloro-2-Bromoethane,Fluothane,Ftorotan,Narcotan
D013943	Thymol	A phenol obtained from thyme oil or other volatile oils used as a stabilizer in pharmaceutical preparations, and as an antiseptic (antibacterial or antifungal) agent.	2-Isopropyl-5-Methyl-Phenol,2-Isopropyl-5-Methylphenol,Phenol, 5-methyl-2-(1-methylethyl)-,Apiguard,2 Isopropyl 5 Methyl Phenol,2 Isopropyl 5 Methylphenol